Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Vitamin D and Omega-3 Trial to Prevent and Treat Diabetic Kidney Disease [ANCILLARY OF 700049031]

X
Trial Profile

Vitamin D and Omega-3 Trial to Prevent and Treat Diabetic Kidney Disease [ANCILLARY OF 700049031]

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Nov 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Colecalciferol (Primary) ; Omega-3-acid ethyl esters (Primary)
  • Indications Diabetic nephropathies
  • Focus Therapeutic Use
  • Acronyms VITAL-DKD
  • Most Recent Events

    • 24 Oct 2020 Results of secondary analysis examining the effects of vitamin D(3) and/or n 3 fatty acid supplementation vs placebo on 5 year changes in serum inflammatory and cardiac biomarkers in adults with type 2 diabetes published in the Diabetologia
    • 10 Jun 2020 Status changed from active, no longer recruiting to completed.
    • 08 Nov 2019 Results published in the JAMA: the Journal of the American Medical Association

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top